(Hypertension. 2002;39:425.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology and Biophysics and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.
Reprint requests to Raouf A. Khalil, MD, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216. E-mail rkhalil{at}physiology.umsmed.edu
| Abstract |
|---|
|
|
|---|
-estradiol) subcutaneous implants, no significant changes in Phe contraction or Ca2+ influx with increases in [Na+]e were observed. In OVX female or castrated male rats simultaneously treated with 17ß-estradiol plus the estrogen receptor antagonist ICI 182,780, the Phe contraction and Ca2+ influx were enhanced with increases in [Na+]e. Thus, in intact male rats, small physiological increases in [Na+]e enhance smooth muscle contraction to Phe by a mechanism involving Ca2+ entry, possibly via the reverse mode of the Na+-Ca2+ exchanger. This mechanism appears to be reduced in the presence of endogenous or exogenous estrogen and thereby protects female rats against excessive increases in vascular reactivity during high dietary Na+ intake.
Key Words: arterial pressure muscle, smooth, vascular calcium sodium gender
| Introduction |
|---|
|
|
|---|
Gender differences in sensitivity to high dietary Na+ have recently been reported in experimental animals, such as the Dahl salt-sensitive rat and the deoxycorticosterone acetate (DOCA)-salt hypertensive rat,1114 and have been explained by gender-specific increases in sympathetic activity and norepinephrine release, reductions in prostacyclin levels, and alterations in the vascular reactivity to vasoconstrictor agonists in males compared with females.1217 Also, in DOCA-salt hypertension, the arterial pressure rises more rapidly and reaches a higher level in male rats than in female rats, and the course of hypertension is exacerbated by gonadectomy in female rats, suggesting that the gender differences in salt sensitivity are possibly related to endogenous gonadal hormones.11,18
During high dietary Na+ intake, several adaptive mechanisms are activated to cope with the large Na+ overload. These mechanisms include expansion of extracellular fluid volume,19 increased cardiac output,20 and increased renal blood flow.21 These adaptive mechanisms make Na+ excretion as equivalent as possible to Na+ intake and thus maintain the body Na+ and the extracellular fluid volume within normal levels. However, some studies have shown that the body Na+ could be higher during high Na+ intake than during low Na+ intake, suggesting that increases in body Na+, albeit small and perhaps temporary, could still occur during a high Na+ diet.22 Also, although the location of the possible increases in body Na+ is not entirely clear, some of the Na+ could be in the cells,23 whereas a significant portion could be in the extracellular fluid volume.19
Although high dietary Na+ could be associated with increases in vascular reactivity to vasoconstrictor agonists16,2426 and could lead to small increases in extracellular Na+ concentration ([Na+]e),22 the direct effect of physiological increases in extracellular Na+ on the mechanisms of vascular smooth muscle contraction is not clearly understood. Vascular smooth muscle contraction is triggered by increases in intracellular Ca2+ that are due to Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space.2729 Also, in activated smooth muscle, the balance between intracellular and extracellular Ca2+ and Na+ is further regulated by the plasmalemmal Na+-Ca2+ exchanger.30,31 In its forward mode, the Na+-Ca2+ exchanger promotes Ca2+ extrusion from the cell, whereas in the reverse mode, it promotes Ca2+ entry into the cell.30,32 However, whether physiological increases in extracellular Na+ enhance vascular reactivity and the Ca2+-handling mechanisms of vascular smooth muscle contraction is unclear. Also, the suggested vascular protective effects of estrogen in females with intact gonads and their proposed absence in males and in females with reduced gonadal function imply that the mechanisms of vascular smooth muscle contraction may be modified by gender and by the presence or absence of functional female gonads.1,33 However, little is known about whether the effects of extracellular Na+ on the mechanisms of vascular smooth muscle contraction are affected by gender and by the presence or absence of gonadal hormones.
The purpose of the present study was to test the hypothesis that physiological increases in [Na+]e enhance the mechanisms of vascular smooth muscle contraction and that the vascular effects of [Na+]e are modified depending on the gender and the presence or absence of gonadal hormones. Experiments were designed to investigate (1) whether small increases in [Na+]e cause or enhance vascular smooth muscle contraction, (2) whether the changes in vascular contraction with increasing [Na+]e involve changes in Ca2+ release from the intracellular stores or Ca2+ entry from the extracellular space or the plasmalemmal Na+-Ca2+ exchange mechanism, and (3) whether the effects of [Na+]e on the mechanisms of vascular smooth muscle contraction exhibit differences depending on the gender and the presence or absence of gonadal hormones.
| Methods |
|---|
|
|
|---|
-estradiol or 17ß-estradiol implant (30-day release, 0.125 mg per pellet, Innovative Research of America) or 17ß-estradiol implant plus daily subcutaneous injection of the estrogen receptor antagonist ICI 182,780 (Tocris, 1 mg/kg per day) 3 days after gonadectomy, and the rats were studied 4 weeks later.34 OVX female and castrated male rats were fed a soy-based diet to minimize dietary intake of phytoestrogens. The plasma 17ß-estradiol was 77±8 pmol/L in intact female rats, 17±2 pmol/L in OVX female rats, 83±9 pmol/L in OVX female rats with 17ß-estradiol implants, 16±2 pmol/L in intact male rats, 18±3 pmol/L in castrated male rats, and 84±6 pmol/L in castrated male rats with 17ß-estradiol implants, as previously described.34 All procedures followed the guidelines of the Institutional Animal Care and Use Committee.
Tissue Preparation
The rats were anesthetized by inhalation of isoflurane. The thoracic aorta was excised, placed in Krebs solution, and cleaned of connective tissue. The aorta was cut transversely into 3-mm-wide strips. Because changes in [Na+]e may affect various types of vascular cells, including endothelial cells, the endothelium was removed by rubbing the vessel interior with wet filter paper.
Isometric Contraction
Aortic strips were transferred to a tissue bath containing Krebs solution bubbled with 95% O2/5% CO2 at 37°C. One end of the strip was fixed to a glass hook, and the other end was connected to a force transducer (Grass FT03C, Astro-Med). The strips were stretched to 1.5 the initial unloaded length and allowed to equilibrate for 1 hour while the changes in tension were displayed on a Grass polygraph (model 7D). After two 96 mmol/L KCl contractions followed by washing with normal Krebs solution, the tissues were incubated for 30 minutes in either (1) Krebs solution containing control [Na+]e (146.2 mmol/L) or containing increasing [Na+]e by the addition of 1, 3, 6, 10, 20, and 30 mmol/L NaCl, (2) Krebs solution containing increasing [Na+]e plus 2,4-dichlorobenzamil (10-5 mol/L), inhibitor of the Na+-Ca2+ exchanger, or KB-R7943 (10-5 mol/L), selective inhibitor of the reverse mode of the Na+-Ca2+ exchange,35 or (3) Krebs solution containing control [Na+]e plus 1, 3, 6, 20, and 30 mmol/L LiCl or N-methyl-D-glucamine. The vascular strips were stimulated with phenylephrine (Phe), and concentration-contraction curves were constructed.
In other experiments, the vascular strips were incubated in Ca2+-free (2 mmol/L EGTA) Krebs solution containing increasing [Na+]e for 5 minutes and then stimulated with Phe (10-5 mol/L) or caffeine (25 mmol/L) to stimulate Ca2+ release from the intracellular stores,27,36 and the resulting transient contraction was measured. The developed force was corrected for the cross-sectional area of the vascular strip and expressed as active stress (N/m2) by using the following equation: stress=force/cross-sectional area, where cross-sectional area is wet weight/(tissue densityxlength of the strip), and tissue density is 1.055 g/cm3.37
45Ca2+ Influx
Vascular strips were incubated for 30 minutes in Krebs solution containing increasing [Na+]e by the addition of 1, 3, 6, 10, 20, and 30 mmol/L NaCl or Krebs solution containing increasing [Na+]e plus the Na+-Ca2+ exchange inhibitor 2,4-dichlorobenzamil or KB-R7943 (10-5 mol/L). The tissues were stimulated with Phe (10-5 mol/L) for 10 minutes and then transferred to the respective radioactive 45Ca2+ (ICN)labeled solution (specific activity 2 µCi/mL) for 90 seconds. Preliminary experiments have shown that the relationship between Ca2+ uptake versus time is linear during 15-, 30-, 60-, and 90-second exposures to the 45Ca2+-labeled solution. The tissues were transferred to ice-cold Ca2+-free (2 mmol/L EGTA) Krebs solution for 45 minutes to quench extracellular 45Ca2+ label. The vascular strips were weighed and placed in 2 mL hypotonic (5 mmol/L) EDTA for 24 hours at 4°C to disrupt the cell membranes and release the intracellular content of 45Ca2+. The next day, 4 mL of Ecolite scintillation cocktail was added, and the 45Ca2+ in the samples was counted in a scintillation counter.28,37
Solutions, Drugs, and Chemicals
Normal Krebs solution contained the following (mmol/L): NaCl 120, KCl 5.9, NaHCO3 25, NaH2PO4 1.2, dextrose 11.5, MgCl2 1.2, and CaCl2 2.5 at pH 7.4. For Ca2+-free Krebs solution, CaCl2 was omitted and replaced with 2 mmol/L EGTA. The high KCl depolarizing solution was prepared as Krebs solution but with equimolar substitution of NaCl with KCl. Stock solution of Phe (10-1 mol/L) was prepared in distilled water. Stock solutions (10-2 mol/L) of 2,4-dichlorobenzamil (Molecular Probes) and KB-R7943 (Tocris) were prepared in dimethyl sulfoxide. The final concentration of dimethyl sulfoxide in solution was
0.1%. Caffeine (25 mmol/L) was directly dissolved in Ca2+-free Krebs solution. All other chemicals were of reagent grade or better.
Statistical Analysis
The data were analyzed and presented as mean±SEM. In intact males, the Phe contraction and 45Ca2+ influx data at increasing [Na+]e and in both the untreated and the dichlorobenzamil-treated or KB-R7943treated vessels were compared by 2-way repeated measures ANOVA followed by the Student-Newman-Keuls post hoc test. The gender difference data were compared by using ANOVA with multiple classification criteria (male versus female rats, intact versus gonadectomized rats, and untreated rats versus rats treated with estrogen), followed by the Bonferroni post hoc test to compare selected groups or the Dunnett post hoc test to compare all groups with intact male rats. Differences were considered statistically significant at P<0.05.
| Results |
|---|
|
|
|---|
|
|
To investigate whether the changes in Phe contraction at increasing [Na+]e reflect increases in Ca2+ entry from the extracellular space, 45Ca2+ influx was measured. In unstimulated vascular strips incubated in Krebs solution containing control [Na+]e (146.2 mmol/L), the basal 45Ca2+ influx was 13.8±1.6 µmol/kg per minute. Phe (10-5 mol/L) caused a significant increase in 45Ca2+ influx (Figure 1C). Preincubation of the vascular strips in Krebs solution containing increasing [Na+]e by the addition of 1, 3, and 6 mmol/L NaCl did not change the basal 45Ca2+ influx but significantly increased the Phe-induced 45Ca2+ influx (Figure 1C). Increases in [Na+]e by the addition of 10, 20, and 30 mmol/L NaCl caused further increases in Phe-induced 45Ca2+ influx (Figure 1C).
In vascular strips pretreated with 2,4-dichlorobenzamil (10-5 mol/L), inhibitor of Na+-Ca2+ exchanger (Figures 2A and 2C), or KB-R7943 (10-5 mol/L), selective inhibitor of the reverse mode of the Na+-Ca2+ exchanger (Figures 2B and 2C), the basal tension and 45Ca2+ influx were not significantly affected; however, the increases in Phe-induced contraction and 45Ca2+ influx at increasing [Na+]e and after the addition of 3 or 6 mmol/L NaCl were reduced to levels not significantly different from the Phe responses in Krebs solution containing control [Na+]e.
|
In vascular strips incubated in Krebs solution containing control [Na+]e plus 1, 3, or 6 mmol/L LiCl (Figure 3A) or N-methyl-D-glucamine (Figure 3B), no significant changes in the basal or Phe-induced contraction were observed. In Krebs solution containing control [Na+]e plus 20 or 30 mmol/L LiCl (Figure 3A) or N-methyl-D-glucamine (Figure 3B), the Phe-induced contraction was significantly reduced.
|
In Ca2+-free (2 mmol/L EGTA) Krebs solution containing control [Na+]e, Phe (10-5 mol/L) and caffeine (25 mmol/L) caused a transient increase in active stress (Table). The Phe- and caffeine-induced stress in Ca2+-free Krebs solution containing increasing [Na+]e by the addition of 1, 3, and 6 mmol/L NaCl was not significantly different from the Phe and caffeine response in Ca2+-free Krebs solution containing control [Na+]e. In Ca2+-free Krebs solution containing increasing [Na+]e by the addition of 10, 20, and 30 mmol/L NaCl, the Phe- and caffeine-induced contractions were significantly reduced (Table).
In vascular strips of intact female rats incubated in Krebs solution containing control [Na+]e, the Phe-induced stress and 45Ca2+ influx were less than that in intact male rats (Figure 4). In intact female rats, increasing [Na+]e by the addition of 6 mmol/L NaCl did not significantly affect the Phe-induced stress or 45Ca2+ influx (Figures 4A and 4C). In intact female rats, larger increases in [Na+]e by the addition of 20 and 30 mmol/L NaCl reduced the maximal Phe-induced stress to 3.9±0.3x104 and 2.8±0.6x104 N/m2, respectively, compared with the maximal Phe stress at control [Na+]e (5.5±0.6x104 N/m2). The enhancement of Phe contraction and Ca2+ influx with increases in [Na+]e by the addition of 6 mmol/L NaCl was greater in OVX female rats than in intact female rats (Figures 4A and 4C) but was not significantly different between castrated and intact male rats (Figures 4B and 4D).
|
In OVX females or castrated male rats treated with the inactive 17
-estradiol subcutaneous implants, significant increases in Phe contraction and Ca2+ influx with increases in [Na+]e obtained by the addition of 6 mmol/L NaCl could still be observed (Figure 5). In OVX female rats or castrated male rats treated with 17ß-estradiol subcutaneous implants, no significant changes in Phe contraction or Ca2+ influx with increases in [Na+]e were observed (Figure 5). In OVX female rats or castrated male rats simultaneously treated with 17ß-estradiol plus the estrogen receptor antagonist ICI 182,780, the Phe-induced contraction and Ca2+ influx were significantly enhanced with increases in [Na+]e obtained by the addition of 6 mmol/L NaCl (Figure 5).
|
| Discussion |
|---|
|
|
|---|
In vascular strips of intact male rats, small increases in [Na+]e by the addition of 1, 3, and 6 mmol/L NaCl enhanced the vascular contraction to Phe. Phe interacts with
-adrenergic receptors in vascular smooth muscle.36 The observation that the Phe EC50 did not change with increases in [Na+]e suggests that the increases in Phe contraction are not likely due to changes in the apparent
-adrenergic receptor affinity. On the other hand, the increases in the magnitude of Phe contraction with small increases in [Na+]e suggest possible enhancement of signaling mechanisms downstream from receptor activation.
Vascular smooth muscle contraction is triggered by increases in intracellular Ca2+ that are due to Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space.2729 The observation that small increases in [Na+]e by the addition of 1, 3, and 6 mmol/L NaCl did not affect the Phe- or caffeine-induced contraction in Ca2+-free solution suggests that the increases in vascular contraction with increases in [Na+]e are not due to the enhancement of Ca2+ release from the intracellular stores. On the other hand, the increases in Phe-induced Ca2+ influx at increasing [Na+]e suggest an enhancement of Ca2+ entry from the extracellular space. The effects of increases in [Na+]e with the use of 1, 3, and 6 mmol/L NaCl on vascular contraction and Ca2+ influx appear to be Na+ specific, inasmuch as similar increases in extracellular salt with the use of LiCl or N-methyl-D-glucamine did not increase Phe contraction or Ca2+ influx.
An important question is how the increases in [Na+]e may increase Ca2+ entry. The increases in [Na+]e are expected to increase the electrochemical gradient for Na+ and stimulate Na+ entry into vascular smooth muscle via nonspecific cation entry pathways, Na+ channels, or Ca2+ channels.31,3840 Although the increases in intracellular Na+ could be extruded via the Na+-K+ pump, the Na+-Ca2+ exchanger has also been suggested to maintain the balance between extracellular and intracellular Na+ and Ca2+ ions.30,31 The observation that the increases in Phe contraction and Ca2+ influx are inhibited by 2,4-dichlorobenzamil, an inhibitor of the Na+-Ca2+ exchanger, suggests that the Na+-Ca2+ exchanger is involved. In its forward mode, the Na+-Ca2+ exchanger is known to play a role in Ca2+ extrusion. On the other hand, the reverse mode of the Na+-Ca2+ exchanger facilitates Na+ extrusion and Ca2+ entry and thereby causes more Na+ to leave the cell and more Ca2+ to enter the cell.30,32 The observation that the increases in Phe contraction and Ca2+ influx with increases in [Na+]e are inhibited by KB-R7943, selective inhibitor of the reverse mode of the Na+-Ca2+ exchanger,35 further suggests the involvement of the Na+-Ca2+ exchanger. Taken together, the present data suggest that small increases in [Na+]e could stimulate small increases in Na+ entry and intracellular Na+, which, in turn, activate the reverse mode of the Na+-Ca2+ exchanger and thereby increase Ca2+ entry. This is supported by reports that small increases in intracellular Na+ concentration are sufficient to generate significant Ca2+ influx in smooth muscle.32
Small increases in [Na+]e did not enhance Phe contraction or Ca2+ influx in vascular strips of intact female rats, which is in contrast to the effect in intact male rats. Chronic studies in Dahl salt-sensitive rats and DOCA-salt hypertensive rats have suggested gender differences in sensitivity to high dietary Na+1114 and have suggested possible alterations in the vascular reactivity in male rats compared with female rats.1217 The present data are in agreement with these reports and provide evidence that small increases in [Na+]e enhance the Ca2+-entry mechanisms of vascular smooth muscle contraction in a gender-specific manner. The lack of enhancement of Phe contraction or Ca2+ influx with small increases in [Na+]e in intact female compared with intact male Sprague-Dawley rats is consistent with previous reports that the Ca2+-entry mechanisms are reduced in female compared with male Wistar-Kyoto and spontaneously hypertensive rats.36 The present results suggest that the reduction in Ca2+ entry in blood vessels of intact female rats may be, at least in part, related to reduction in the reverse mode of the Na+-Ca2+ exchanger.
Chronic studies in DOCA-salt hypertensive rats have shown that the arterial pressure is greater in male rats than in female rats and that the hypertension is exacerbated by gonadectomy in female rats, suggesting that the gender differences in salt sensitivity are related to endogenous gonadal hormones.11,18 The present acute studies agree with these reports and suggest that the gender differences in the sensitivity to increasing [Na+]e may be related to estrogen, because the enhancements of Phe contraction and Ca2+ influx with increases in [Na+]e were (1) not significantly different between castrated male rats and intact male rats, (2) significantly greater in OVX female rats than in intact female rats, and (3) not observed in OVX female rats or castrated male rats treated with 17ß-estradiol subcutaneous implants. Also, the inhibitory effects of estrogen appear to be specific, because the enhancements of Phe contraction and Ca2+ influx with increases in [Na+]e could still be observed in OVX female rats or castrated male rats treated with the inactive 17
-estradiol subcutaneous implants and in OVX female rats or castrated male rats simultaneously treated with 17ß-estradiol plus the estrogen receptor antagonist ICI 182,780. However, whether treatment of intact females with ICI 182,780 can unveil the enhancing effects of small increases in [Na+]e on vascular reactivity and Ca2+ influx remains to be investigated. Also, the mechanisms by which estrogen might affect the Na+-Ca2+ exchanger are unclear at the present time but may be related to decreased expression and/or activity of the exchanger.
In the present study, larger increases in [Na+]e by the addition of 20 and 30 mmol/L NaCl were associated with significant reduction in Phe contraction despite increases in Ca2+ influx. This can be explained by the possibility that the enhancements of vascular contraction and Ca2+ influx by the increases in [Na+]e are counterbalanced by inhibitory effects due to increases in extracellular ionic strength. It has been reported that increases in extracellular ionic strength reduce muscle contraction, possibly because of changes in the actual spacing between the actin and myosin filaments.41 This is supported by the present observations that (1) increases in [Na+]e by the addition of 20 and 30 mmol/L NaCl caused significant reduction in Phe contraction in both male and female rats, (2) increases in [Na+]e by the addition of 10, 20, and 30 mmol/L NaCl caused significant reduction in Phe- and caffeine-induced vascular contraction in Ca2+-free solution, and (3) increases in ionic strength with the use of 20 and 30 mmol/L LiCl or N-methyl-D-glucamine caused significant reduction in Phe contraction, providing further evidence that the inhibition of contraction with large increases in [Na+]e is possibly due to excessive increases in extracellular ionic strength and may mask significant vasoconstrictor effects of physiological increases in [Na+]e.
The present study highlights the importance of studying the effects of small and physiological increases in [Na+]e on vascular function in both males and females. Although small increases in [Na+]e enhance vascular contraction and intracellular Ca2+ entry in male rats, these effects appear to be reduced in female rats. We should emphasize that the present study examined the effect of brief exposures to increases in [Na+]e on vascular contraction in ex vivo conditions. Whether these effects occur in vivo is unclear; however, frequent brief exposures to small increases in [Na+]e may have long-term cumulative vasoconstrictive effects on the vasculature. Also, in the present study, [Na+]e was increased relative to a control [Na+]e of 146.2 mmol/L. Because the control [Na+]e may vary in different animal species and in humans, it is important to take into consideration the species differences in the control physiological [Na+]e in studies involving the effect of increases in [Na+]e on vascular function. Finally, in the present study, the extracellular concentration of not only Na+ but also Cl- has been changed; thus, it would be difficult to rule out an effect of extracellular Cl- under these conditions. Future studies should test the effects of increasing extracellular Na+ while keeping Cl- constant and vice versa.
Thus, in intact male rats, small physiological increases in [Na+]e enhance vascular smooth muscle contraction to Phe by a mechanism possibly involving Ca2+ entry via the reverse mode of the Na+-Ca2+ exchanger. This mechanism appears to be reduced in the presence of endogenous or exogenous estrogen and thereby protects females against excessive increases in vascular reactivity during high dietary Na+ intake.
| Acknowledgments |
|---|
Received September 23, 2001; first decision October 29, 2001; accepted November 7, 2001.
| References |
|---|
|
|
|---|
2. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon ROIII. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994; 90: 786791.
3. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen?: from bedside to bench. Circulation. 1995; 92: 58.
4. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996; 10: 615624.[Abstract]
5. Houston MC. Sodium and hypertension: a review. Arch Intern Med. 1986; 146: 179185.
6. Tobian L. Salt and hypertension: lessons from animal models that relate to human hypertension. Hypertension. 1991; 17 (suppl I): I-52I-58.[Medline] [Order article via Infotrieve]
7. Kuller LH. Salt and blood pressure: population and individual perspectives. Am J Hypertens. 1997; 10(pt 2): 29S36S.
8. Nurminen ML, Korpela R, Vapaatalo H. Dietary factors in the pathogenesis and treatment of hypertension. Ann Med. 1998; 30: 143150.[Medline] [Order article via Infotrieve]
9. Nestel PJ, Clifton PM, Noakes M, McArthur R, Howe PR. Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. J Hypertens. 1993; 11: 13871394.[Medline] [Order article via Infotrieve]
10. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses health study. N Engl J Med. 1991; 325: 756762.[Abstract]
11. Crofton JT, Share L. Gonadal hormones modulate deoxy-corticosterone-salt hypertension in male and female rats. Hypertension. 1997; 29(pt 2): 494499.
12. Tostes RC, David FL, Carvalho MH, Nigro D, Scivoletto R, Fortes ZB. Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats. J Cardiovasc Pharmacol. 2000; 36 (suppl 1): S99S101.[Medline] [Order article via Infotrieve]
13. Tostes Passaglia RC, David FL, Fortes ZB, Nigro D, Scivoletto R, Catelli De Carvalho MH. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ETB receptor-mediated vascular responses. Br J Pharmacol. 2000; 130: 10921098.[CrossRef][Medline] [Order article via Infotrieve]
14. Bayorh MA, Socci RR, Eatman D, Wang M, Thierry-Palmer M. The role of gender in salt-induced hypertension. Clin Exp Hypertens. 2001; 23: 241255.[CrossRef][Medline] [Order article via Infotrieve]
15. Ouchi Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension. 1987; 9: 172177.
16. Ouchi Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. J Hypertens. 1988; 6: 381387.[Medline] [Order article via Infotrieve]
17. Stallone JN. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats. Am J Physiol. 1995; 268(pt 2): R40R49.
18. Crofton JT, Share L, Brooks DP. Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat. Clin Exp Hypertens A. 1989; 11: 12491261.[Medline] [Order article via Infotrieve]
19. Skorecki KL, Brenner BM. Body fluid homeostasis in man: a contemporary overview. Am J Med. 1981; 70: 7788.[CrossRef][Medline] [Order article via Infotrieve]
20. Sullivan JM, Ratts TE. Hemodynamic mechanisms of adaptation to chronic high sodium intake in normal humans. Hypertension. 1983; 5: 814820.
21. Rich GM, McCullough M, Olmedo A, Malarick C, Moore TJ. Blood pressure and renal blood flow responses to dietary calcium and sodium intake in humans. Am J Hypertens. 1991; 4: 642S645S.[Medline] [Order article via Infotrieve]
22. Brown WJ Jr, Brown FK, Krishan I. Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation. 1971; 43: 508519.
23. Ambrosioni E, Costa FV, Borghi C, Montebugnoli L, Giordani MF, Magnani B. Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension. Hypertension. 1982; 4: 789794.
24. Egan BM, Petrin J, Hoffmann RG. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991; 4(pt 1): 924931.
25. Adegunloye BJ, Sofola OA. Effect of dietary salt loading and high-calcium diet on vascular smooth muscle responses and endothelium function in rats. Clin Exp Pharmacol Physiol. 1997; 24: 814818.[Medline] [Order article via Infotrieve]
26. Watts SW. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J Hypertens. 1998; 16: 811822.[CrossRef][Medline] [Order article via Infotrieve]
27. Khalil RA, van Breemen C. Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension.In: Laraagh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1995: 523540.
28. Kanashiro CA, Khalil RA. Isoform-specific protein kinase C activity at variable Ca2+ entry during coronary artery contraction by vasoactive eicosanoids. Can J Physiol Pharmacol. 1998; 76: 11101119.[CrossRef][Medline] [Order article via Infotrieve]
29. Murphy JG, Khalil RA. Decreased [Ca2+]i during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther. 1999; 291: 4452.
30. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev. 1999; 79: 763854.
31. Arnon A, Hamlyn JM, Blaustein MP. Na+ entry via store-operated channels modulates Ca2+ signaling in arterial myocytes. Am J Physiol. 2000; 278: C163C173.
32. Wu C, Fry CH. Na+/Ca2+ exchange and its role in intracellular Ca2+ regulation in guinea pig detrusor smooth muscle. Am J Physiol. 2001; 280: C1090C1096.
33. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983; 12: 123.[Medline] [Order article via Infotrieve]
34. Kanashiro CA, Khalil RA. Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol. 2001; 280: C34C45.
35. Ladilov Y, Haffner S, Balser-Schafer C, Maxeiner H, Piper HM. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol. 1999; 276(p 2): H1868H1876.
36. Murphy JG, Khalil RA. Gender-specific reduction in contractility and [Ca2+]i in vascular smooth muscle cells of female rat. Am J Physiol. 2000; 278: C834C844.
37. Crews JK, Novak J, Granger JP, Khalil RA. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol. 1999; 276: R530R538.[Medline] [Order article via Infotrieve]
38. Quignard JF, Ryckwaert F, Albat B, Nargeot J, Richard S. A novel tetrodotoxin-sensitive Na+ current in cultured human coronary myocytes. Circ Res. 1997; 80: 377382.[Medline] [Order article via Infotrieve]
39. Cox RH, Zhou Z, Tulenko TN. Voltage-gated sodium channels in human aortic smooth muscle cells. J Vasc Res. 1998; 35: 310317.[CrossRef][Medline] [Order article via Infotrieve]
40. Boccara G, Choby C, Frapier JM, Quignard JF, Nargeot J, Dayanithi G, Richard S. Regulation of Ca2+ homeostasis by atypical Na+ currents in cultured human coronary myocytes. Circ Res. 1999; 85: 606613.
41. Godt RE, Kirby AC, Gordon AM. Effects of hypertonic solutions on contraction of frog tonic muscle fibers. Am J Physiol. 1984; 246(pt 1): C148C153.
This article has been cited by other articles:
![]() |
M. P. Kunert, M. R. Dwinell, I. Drenjancevic Peric, and J. H. Lombard Sex-specific differences in chromosome-dependent regulation of vascular reactivity in female consomic rat strains from a SS x BN cross Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R516 - R527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Bauser-Heaton, J. Song, and H. G. Bohlen Cerebral microvascular nNOS responds to lowered oxygen tension through a bumetanide-sensitive cotransporter and sodium-calcium exchanger Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2166 - H2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Pojoga, T. M. Yao, S. Sinha, R. L. Ross, J. C. Lin, J. D. Raffetto, G. K. Adler, G. H. Williams, and R. A. Khalil Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1258 - H1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Paul, P. S. Bowman, J. Johnson, and A. F. Martin Effects of sex and estrogen on myosin COOH-terminal isoforms and contractility in rat aorta Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R751 - R757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil Dietary salt and hypertension: new molecular targets add more spice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R509 - R513. [Full Text] [PDF] |
||||
![]() |
B. G. Zani and H. G. Bohlen Transport of extracellular L-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1381 - H1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Zani and H. G. Bohlen Sodium channels are required during in vivo sodium chloride hyperosmolarity to stimulate increase in intestinal endothelial nitric oxide production Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H89 - H95. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |